Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain

Neuroscience

Volumn 124, Issue 4, 2004, Pages 891-900

  Broom, D C ^a   Samad, T A ^a   Kohno, T ^a   Tegeder, I ^a,b   Geisslinger, G ^b   Woolf, C J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

amino 3 hydroxy 5 methyl 4 isoxazole propanoic acid; ACSF; Allodynia; AMPA; Artificial cerebrospinal fluid; CFA; Complete Freund's adjuvant; COX; Cyclooxygenase; Dimethylsulfoxide; DMSO; Hyperalgesia; Partial nerve injury; Rofecoxib; Spinal dorsal horn

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FREUND ADJUVANT; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; RIBONUCLEASE; ROFECOXIB;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME REGULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HINDLIMB; HYPERALGESIA; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NERVE CELL; NERVE INJURY; NERVE SURGERY; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RIBONUCLEASE PROTECTION ASSAY; SPINAL CORD; SPINAL CORD DORSAL HORN;

ANIMALS; BEHAVIOR, ANIMAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIALYSIS SOLUTIONS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; HYPERALGESIA; HYPERESTHESIA; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LACTONES; MICRODIALYSIS; NEURALGIA; NUCLEASE PROTECTION ASSAYS; OSMOLAR CONCENTRATION; PAIN THRESHOLD; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEASES; RNA, MESSENGER; SULFONES;

EID: 1542351147     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.01.003     Document Type: Article

References (40)

1. 2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci. 5:2002;34-40.
2. Amaya F., Decosterd I., Samad T.A., Plumpton C., Tate S., Mannion R.J., Costigan M., Woolf C.J. Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol Cell Neurosci. 15:2000;331-342.
3. Baba H., Doubell T.P., Woolf C.J. Peripheral inflammation facilitates Aβ fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord. J Neurosci. 19:1999;859-867.
4. Baba H., Kohno T., Moore K.A., Woolf C.J. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci. 21:2001;1750-1756.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
6. Chan C.-C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Ford-Hutchinson A.W., Forrest M.J., Gauthier J.Y., Gordon R., Gresser M., Guay J., Kargman S., Kennedy B., Leblanc Y., Leger S., Mancini J., O'Neill G.P., Ouellet M., Patrick D., Percival M.D., Perrier H., Prasit P., Rodger I., Tagari P., Therien M., Vickers P., Visco D., Wang Z., Webb J., Wong E., Xu L.-J., Young R.N., Zamboni R., Riendeau D. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone] A potent and orally active cyclooxygenase-2 inhibitor: pharmacological and biochemical profiles. J Pharmacol Exp Ther. 290:1999;551-560.
7. Chandrasekharan NV, Dai H, Tarepu Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA; published online: 19 September, 10.1073/pnas. 162468699.
8. Decosterd I., Woolf C.J. Spared nerve injury An animal model of persistent peripheral neuropathic pain. Pain. 87:2000;149-158.
9. Dirig D.M., Yaksh T.L. In vitro prostanoid release from spinal cord following peripheral inflammation Effects of substance p, nmda and capsaicin. Br J Pharmacol. 126:1999;1333-1340.
10. 2 release by flurbiprofen enantiomers A microdialysis study. J Neurochem. 74:2000;2094-2100.
11. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
12. Hay C.H., Trevethick M.A., Wheeldon A., Bowers J.S., De Belleroche J.S. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience. 78:1997;843-850.
13. Ichitani Y., Shi T., Haeggstrom J.Z., Samuelsson B., Hokfelt T. Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation An in situ hybridization study. Neuroreport. 8:1997;2949-2952.
14. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
15. Kohno T., Kumamoto E., Higashi H., Shimoji K., Yoshimura M. Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. J Physiol (Lond). 518:1999;803-813.
16. Ma W., Du W., Eisenach J.C. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 937:2002;94-99.
17. Ma W., Eisenach J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci. 15:2002;1037-1047.
18. 2 and amino acids evoked by paw formalin injection A microdialysis study in unanesthetized rats. J Neurosci. 15:1995;2768-2776.
19. McCleskey E.W., Gold M.S. Ion channels of nociception. Annu Rev Physiol. 61:1999;835-856.
20. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., Woolf C.J. Partial but not complete peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci. 22:2002;6724-6731.
21. Niederberger E., Tegeder I., Schafer C., Seegel M., Grosch S., Geisslinger G. Opposite effects of rofecoxib on nuclear factor-κB and activating protein-1 activation. J Pharmacol Exp Ther. 304:2003;1153-1160.
22. O'Banion M.K. Cyclooxygenase-2 Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol. 13:1999;45-82.
23. Omana-Zapata I., Bley K.R. A stable prostacyclin analog enhances ectopic activity in rat sensory neurons following neuropathic injury. Brain Res. 904:2001;85-92.
24. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., Woolf C.J. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 410:2001;471-475.
25. Samad T.A., Sapirstein A., Woolf C.J. Prostanoids and pain Unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 8:2002;390-396.
26. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
27. Shen F., Bai A.P., Guo Z.R., Cheng G.F. Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-1 derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages. Acta Pharmacol Sin. 23:2002;762-768.
28. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain An update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
29. Southall M.D., Michael R.L., Vasko M.R. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain. 78:1998;39-48.
30. Syriatowicz J.-P., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve injury Role of prostaglandins. Neuroscience. 94:1999;587-594.
31. Taiwo Y.O., Levine J.D. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res. 537:1990;372-374.
32. 2 release in the spinal cord. J Neurochem. 79:2001;777-786.
33. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15:2001;2057-2072.
34. Vasquez E., Bar K.-J., Ebersberger A., Klein B., Vanegas H., Schaible H.-G. Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci. 21:2001;9001-9008.
35. Woolf C.J., Mannion R.J. Neuropathic pain Aetiology, symptoms, mechanisms, and management. Lancet. 353:1999;1959-1964.
36. 2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci. 21:2001;5847-5853.
37. Yamamoto T., Nozaki-Taguchi N. Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carrageenan injection in the rat. Neuroreport. 8:1997;2179-2182.
38. 2 release after carrageenan/kaolin-induced knee joint inflammation A chronic microdialysis study. Pain. 67:1996;345-354.
39. Yoshimura M., Nishi S. Blind patch-clamp recordings from substantia gelatinosa neurons in adult rat spinal cord slices Pharmacological properties of synaptic currents. Neuroscience. 53:1993;519-526.
40. Zhao Z., Chen S.R., Eisenach J.C., Busija D.W., Pan H.L. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience. 97:2000;743-748.